NSC5548

NSC5548 is a lipid of Polyketides (PK) class. Nsc5548 is associated with abnormalities such as Diabetes Mellitus, Non-Insulin-Dependent, Hyperglycemia, Coronary Arteriosclerosis, Liver diseases and Pulmonary Edema. The involved functions are known as Increased Sensitivy, Taste Perception, Cell Death, Phosphorylation and Signal Transduction. Nsc5548 often locates in Oral region, Cytoskeleton, Hepatic, Blood and Mouse Bone Marrow. The associated genes with NSC5548 are CA2 gene, P4HTM gene, FPGT gene, glycyl-L-phenylalanine and glycylphenylalanine. The related lipids are butyrate, Lipid Peroxides, blood lipid, Sterols and Total cholesterol.

Cross Reference

Introduction

To understand associated biological information of NSC5548, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with NSC5548?

NSC5548 is suspected in Hyperglycemia, Osteoporosis, Diabetes Mellitus, Non-Insulin-Dependent, Coronary Arteriosclerosis, Liver diseases, Pulmonary Edema and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with NSC5548

MeSH term MeSH ID Detail
Neurotoxicity Syndromes D020258 34 associated lipids
Uveitis, Posterior D015866 5 associated lipids
Chromosomal Instability D043171 5 associated lipids
Per page 10 20 50 | Total 23

PubChem Associated disorders and diseases

What pathways are associated with NSC5548

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with NSC5548?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with NSC5548?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with NSC5548?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with NSC5548?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with NSC5548?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with NSC5548

Download all related citations
Per page 10 20 50 100 | Total 283
Authors Title Published Journal PubMed Link
Liu M et al. Toxicokinetics of naringin, a putative antitussive, after 184-day repeated oral administration in rats. 2011 Environ. Toxicol. Pharmacol. pmid:21787720
Oki K et al. The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line. 2012 Endocrinology pmid:22798349
Lambev I et al. [Antiexudative effect of naringin in experimental pulmonary edema and peritonitis]. 1980 Eksp Med Morfol pmid:7460808
Miyazaki N et al. Effects of itraconazole, dexamethasone and naringin on the pharmacokinetics of nadolol in rats. 2013 Drug Metab. Pharmacokinet. pmid:23419354
Shirasaka Y et al. Intestinal absorption of HMG-CoA reductase inhibitor pitavastatin mediated by organic anion transporting polypeptide and P-glycoprotein/multidrug resistance 1. 2011 Drug Metab. Pharmacokinet. pmid:21206133
Drewnowski A et al. Genetic taste markers and food preferences. 2001 Drug Metab. Dispos. pmid:11259346
Parmar HS et al. DPP-IV inhibitory potential of naringin: an in silico, in vitro and in vivo study. 2012 Diabetes Res. Clin. Pract. pmid:22410395
Luo Z et al. Effects of pH on the ability of flavonoids to act as Pickering emulsion stabilizers. 2012 Colloids Surf B Biointerfaces pmid:22197223
Bailey DG et al. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. 2007 Clin. Pharmacol. Ther. pmid:17301733
Bailey DG et al. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. 1993 Clin. Pharmacol. Ther. pmid:8275614
Bailey DG et al. Grapefruit juice--felodipine interaction: mechanism, predictability, and effect of naringin. 1993 Clin. Pharmacol. Ther. pmid:8513655
Bailey DG et al. Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients. 2000 Clin. Pharmacol. Ther. pmid:11103749
Bailey DG et al. Grapefruit juice-felodipine interaction: effect of naringin and 6',7'-dihydroxybergamottin in humans. 1998 Clin. Pharmacol. Ther. pmid:9757148
Yamakawa Y et al. Pharmacokinetic impact of SLCO1A2 polymorphisms on imatinib disposition in patients with chronic myeloid leukemia. 2011 Clin. Pharmacol. Ther. pmid:21633340
Ballard TL et al. Naringin does not alter caffeine pharmacokinetics, energy expenditure, or cardiovascular haemodynamics in humans following caffeine consumption. 2006 Clin. Exp. Pharmacol. Physiol. pmid:16620293
Jeon SM et al. Comparison of antioxidant effects of naringin and probucol in cholesterol-fed rabbits. 2002 Clin. Chim. Acta pmid:11814474
Jagetia GC et al. Influence of naringin on ferric iron induced oxidative damage in vitro. 2004 Clin. Chim. Acta pmid:15313158
Bailey DG et al. Grapefruit juice and drugs. How significant is the interaction? 1994 Clin Pharmacokinet pmid:8162660
Jung UJ et al. Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. 2003 Clin Nutr pmid:14613759
Jeon SM et al. Antihypercholesterolemic property of naringin alters plasma and tissue lipids, cholesterol-regulating enzymes, fecal sterol and tissue morphology in rabbits. 2004 Clin Nutr pmid:15380892
Caccamese S et al. Chiral HPLC separation and CD spectra of the C-2 diastereomers of naringin in grapefruit during maturation. 2003 Chirality pmid:12923803
Gong HL et al. Effect of formula compatibility on the pharmacokinetics of components from Dachengqi Decoction [See Text] in rats. 2012 Chin J Integr Med pmid:22936325
Wang JN et al. Population pharmacokinetics of naringin in total flavonoids of Drynaria fortunei (Kunze) J. Sm. in Chinese women with primary osteoporosis. 2012 Chin J Integr Med pmid:23239001
Maehashi K et al. Riboflavin-binding protein is a novel bitter inhibitor. 2008 Chem. Senses pmid:17846099
Dai H et al. A highly sensitive and selective sensing ECL platform for naringin based on β-Cyclodextrin functionalized carbon nanohorns. 2011 Chem. Commun. (Camb.) pmid:21975830
Jagetia GC and Reddy TK Alleviation of iron induced oxidative stress by the grape fruit flavanone naringin in vitro. 2011 Chem. Biol. Interact. pmid:21345335
Ozyürek M et al. Novel oxime based flavanone, naringin-oxime: synthesis, characterization and screening for antioxidant activity. 2014 Chem. Biol. Interact. pmid:24508591
Amudha K and Pari L Beneficial role of naringin, a flavanoid on nickel induced nephrotoxicity in rats. 2011 Chem. Biol. Interact. pmid:21600195
Shaik N et al. Inhibition of Ca(2+) entry and suicidal erythrocyte death by naringin. 2012 Cell. Physiol. Biochem. pmid:22854627
Seto E et al. Patch clamp recording of the responses to three bitter stimuli in mouse taste cells. 1999 Cell. Mol. Biol. (Noisy-le-grand) pmid:10386788
Ahmad SF et al. Amelioration of autoimmune arthritis by naringin through modulation of T regulatory cells and Th1/Th2 cytokines. 2014 Cell. Immunol. pmid:24487035
Krakstad C et al. CaM-kinaseII-dependent commitment to microcystin-induced apoptosis is coupled to cell budding, but not to shrinkage or chromatin hypercondensation. 2006 Cell Death Differ. pmid:16311514
Blankson H et al. Prevention of toxin-induced cytoskeletal disruption and apoptotic liver cell death by the grapefruit flavonoid, naringin. 2000 Cell Death Differ. pmid:10918448
Russo A et al. Bioflavonoids as antiradicals, antioxidants and DNA cleavage protectors. 2000 Cell Biol. Toxicol. pmid:10917564
Kim DI et al. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression. 2008 Carcinogenesis pmid:18296682
Vanamala J et al. Suppression of colon carcinogenesis by bioactive compounds in grapefruit. 2006 Carcinogenesis pmid:16387741
Pang WY et al. Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells. 2010 Br. J. Pharmacol. pmid:20397301
Yow TT et al. Naringin directly activates inwardly rectifying potassium channels at an overlapping binding site to tertiapin-Q. 2011 Br. J. Pharmacol. pmid:21391982
Sharma AK et al. Up-regulation of PPARγ, heat shock protein-27 and -72 by naringin attenuates insulin resistance, β-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes. 2011 Br. J. Nutr. pmid:21736771
Leray V et al. Effect of citrus polyphenol- and curcumin-supplemented diet on inflammatory state in obese cats. 2011 Br. J. Nutr. pmid:22005428
Tramice A et al. Direct enzymatic glucosylation of naringin in grapefruit juice by alpha-D-glucosidase from the marine mollusc Aplysia fasciata. 2008 Biotechnol J pmid:18098121
Kometani T et al. Synthesis of neohesperidin glycosides and naringin glycosides by cyclodextrin glucanotransferase from an alkalophilic Bacillus species. 1996 Biosci. Biotechnol. Biochem. pmid:8829532
Kawaguchi K et al. Hesperidin as an inhibitor of lipases from porcine pancreas and Pseudomonas. 1997 Biosci. Biotechnol. Biochem. pmid:9028038
Akiyama T et al. Naringin glycosides alpha-glucosylated on ring B found in the natural food additive, enzymatically modified naringin. 2000 Biosci. Biotechnol. Biochem. pmid:11129606
Soria F and Ellenrieder G Thermal inactivation and product inhibition of Aspergillus terreus CECT 2663 alpha-L-rhamnosidase and their role on hydrolysis of naringin solutions. 2002 Biosci. Biotechnol. Biochem. pmid:12224626
Ichinose H et al. Characterization of an α-L-Rhamnosidase from Streptomyces avermitilis. 2013 Biosci. Biotechnol. Biochem. pmid:23291751
Liu Q et al. Cell surface engineering of α-l-rhamnosidase for naringin hydrolysis. 2012 Bioresour. Technol. pmid:22940311
Martearena MR et al. Synthesis of alkyl-alpha-L-rhamnosides by water soluble alcohols enzymatic glycosylation. 2003 Bioresour. Technol. pmid:14575952
Nunes MA et al. Microtiter plates versus stirred mini-bioreactors in biocatalysis: a scalable approach. 2013 Bioresour. Technol. pmid:23563437
Liu M et al. Metabolism and excretion studies of oral administered naringin, a putative antitussive, in rats and dogs. 2012 Biopharm Drug Dispos pmid:22374702